comparemela.com

Latest Breaking News On - Integrated diagnostic solutions - Page 2 : comparemela.com

One-third of women avoid a gynaecology visit due to embarrassment

A survey found that 59 per cent of women in the UK have delayed a gynaecology visit; with a third avoiding going due to embarrassment.

United kingdomNew zealandPap papanicolaouLaura forsythDrjeff andrewsHarris pollJeff andrewsIntegrated diagnostic solutions

BD Reports First Quarter Fiscal 2024 Financial Results

Margin Execution Drives Better Performance in Quarter and Higher Guidance for Fiscal 2024 Q1 revenue of $4.7 billion increased 2.6% as reported, 1.6% currency-neutral and 2.4% organicQ1 GAAP and.

United statesTroy kirkpatrickTom polenResearch instrumentsBd life sciencesWorld economic forum zero health gaps pledgeCatheter solutionsDiagnostics solutionsEuropean union medical device regulationMedication delivery solutionsExchange commissionMedication management solutionsClinical solutionsFillable solutionsMargin execution drives better performanceHigher guidance

Becton Dickinson & Co (BDX) Reports Q1 Fiscal 2024 Results: Margin Execution Leads to

BDX Sees Organic Revenue Growth and Raises Full-Year Adjusted EPS Guidance

Tom polenBd life sciencesMedication management solutionsBecton dickinson coRevenue growthPharmaceutical systemsCritical careIntegrated diagnostic solutionsBecton dickinsonRevenue increaseQ1 revenue

BD - New Survey by the Harris Poll Highlights Gaps in Cervical Cancer Screening Access

FRANKLIN LAKES - BD , a leading global medical technology company, today announced the results of a Harris Poll survey of women in the U.S., U.K. and Sweden, which shines a spotlight on the.

New zealandUnited statesTroy kirkpatrickJeff andrewsPap papanicolaouDrug administrationWorld health organizationAmerican cancer societyHarris pollHealth organizationDiagnostic solutionsCancer societyIntegrated diagnostic solutionsNews publishing

BD Reports Fourth Quarter and Full Year Fiscal 2023 Financial Results

Execution of BD 2025 Strategy Driving Durable, Broad-Based Growth Q4 revenue of $5.1 billion increased 6.8% as reported and 5.9% on a currency-neutral basis Q4.

United statesTroy kirkpatrickTransjugular intrahepatic portosystemicTom polenEmbecta corpRevenue growthBd life sciences revenuesBd life sciencesLife sciencesSolutions revenuesDiagnostics solutionsMedication management solutionsResearch instrumentsMedication delivery solutionsEuropean union medical device regulationCasella waste systems inc

vimarsana © 2020. All Rights Reserved.